BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
SINGAPORE, March 28, 2023 /PRNewswire/ -- Becton Dickinson Holdings Pte Ltd (BD), a global leader in life science technologies, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have announced an extended research partnership that will focus on deep immunophenotyping of human tissues using spectral flow...
Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC
Amway leverages its extensive R&D capabilities and innovation agility to drive its customer-driven product development strategy. SAN ANTONIO, March 28, 2023 /PRNewswire/ -- Frost & Sullivan recently analyzed the home water treatment (HWT) industry and, based on its assessment results, recognizes Amway with the 2022 Asia-Pacific (APAC) Competitive Strategy Leadership Award. Amway is a global entrepreneur-led health and wellness company...
Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV
Tavneos® newly introduced in the 2022 European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of ANCA-associated vasculitis (AAV) Recommendations recognize Tavneos®' ability to induce and sustain remission, lower glucocorticoids-induced toxic effects and potentially improve renal function in patients with GPA/MPA ST. GALLEN, Switzerland, March 28, 2023 /PRNewswire/ --...
Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors
ALAMEDA, Calif. and TAIPEI, March 28, 2023 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC) technology to address gaps in cancer care, today announced the upcoming poster presentation of new preclinical data for ACE2016, a gamma delta-2 T cell therapy designed to target EGFR expressing solid tumors. The company...
HaemaLogiX to present final data from anti-KMA CAR-T preclinical studies at AACR
SYDNEY, March 28, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage biotech company developing novel immunotherapies for multiple myeloma, today announced that its anti-KMA CAR-T cell preclinical development has been completed and is the subject of an abstract accepted for poster presentation at the 2023 Annual Meeting of the American Association for Cancer Research (AACR), held 14-19 April in...
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
SHANGHAI, March 28, 2023 /PRNewswire/ -- BJ Bioscience, Inc. BJ Bioscience, a biotech company focusing on discovery and development of novel biologics for cancer immunotherapy, today announced that it entered into a clinical trial collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA). The collaboration will allow for the evaluation of safety and efficacy...
BioDuro-Sundia Announces Formation of Scientific Advisory Board
IRVINE, Calif., March 28, 2023 /PRNewswire/ -- BioDuro-Sundia, a leading drug discovery, development and commercial services organization backed by Advent International, announced today the establishment of a Discovery Research Scientific Advisory Board (SAB) with the appointment of Andrew Thomas Ph.D. and Zach Sweeney Ph.D. as its members. The SAB will advise BioDuro-Sundia as the company is growing its discovery...
Boan Biotech Announces 2022 Financial Results
Showing accelerated innovation and strong 225% revenue growth YANTAI, China, March 27, 2023 /PRNewswire/ -- Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights Record high in revenue: In 2022, Boan Biotech's revenue was approximately RMB 516 million, representing a strong growth of 225% from 2021, mainly attributable to the fast sales...
CGTN: How China keeps its promise to build a community of common health for mankind
BEIJING, March 27, 2023 /PRNewswire/ -- Recognizing China for its support during the pandemic, the Senate of the Dominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the award ceremony that the Dominican Republic will always remember China's timely assistance in its darkest hour, and the bilateral cooperation against COVID-19 is regarded...
Noul Co. Ltd – The RIGHT Foundation Commences Research and Development for Supporting Malaria Control
Aim to accelerate global business and access to the public market based on reliable research results Grant funds will be utilized for global clinical studies and cost-effectiveness analysis of the miLab™ Platform over the next three years YONGIN, South Korea, March 27, 2023 /PRNewswire/ -- Noul Co. Ltd (CEO : David...
